Wrona, Paweł
Wróbel, Dominik
Mizera, Paweł
Jóźwik, Joanna
Jakobschy, Klaudia
Zdrojewska, Kaja
Homa, Tomasz
Sawczyńska, Katarzyna
Popiela, Tadeusz
Słowik, Agnieszka
Turaj, Wojciech
Funding for this research was provided by:
iBioStroke (ERA-NET-NEURON/21/2020, K/NCB/00057))
Uniwersytet Jagielloński Collegium Medicum ((N41/DBS/000837))
Article History
Received: 24 April 2024
Accepted: 9 August 2024
First Online: 17 August 2024
Declarations
:
: W.T. has received honoraria for publications from Sanofi-Genzyme and honoraria for lectures, travel expenses, and conference fees from Shire, Takeda, CSL Behring, and Merck (unrelated to the topic of this article). The other authors declare that there are no conflicts of interest.
: Written informed consent was obtained from patients or, in cases where it could not be provided by patients due to severe condition, their legal representatives.
: This study was approved by the Jagiellonian University Ethical Committee (decision numbers KBET/54/B/2007, 1072.6120.118.2020 and 1072.6120.256.2022).